Iodide

Iodide

SCHEMBL22204584

C[n+]1ccc(-c2ccc(C(=O)O)cc2)cc1.[I-]

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SLC22A2 O15244 1/20 0.52
SLC22A1 O15245 1/20 0.52
SLC22A3 O75751 1/20 0.52
SLC6A4 P31645 1/20 0.52
BCL2L1 Q07817 1/20 0.52
BAD Q92934 1/20 0.52
RXRA P19793 4/20 0.52
RXRB P28702 3/20 0.52
TP53 P04637 1/20 0.50
TSHR P16473 1/20 0.50
HSD17B10 Q99714 2/20 0.48
RXRG P48443 1/20 0.47
KDM4E B2RXH2 1/20 0.47
LMNA P02545 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12160935 0.84 TSHR (0.55) SLC22A2SLC22A1SLC22A3SLC6A4TP53
SCHEMBL16000663 0.83 QDPR (0.50) SLC22A2SLC22A1SLC22A3SLC6A4LMNA
Hydrochloric Acid SCHEMBL28336463 0.82 TSHR (0.52) SLC22A2SLC22A1SLC22A3SLC6A4TP53
Hydrochloric Acid SCHEMBL19877380 0.82 TSHR (0.52) SLC22A2SLC22A1SLC22A3SLC6A4TP53
SCHEMBL15423843 0.80 RAB9A (0.60) SLC22A2SLC22A1SLC22A3SLC6A4LMNA
SCHEMBL22204594 0.79 USP2 (0.50) SLC22A2SLC22A1SLC22A3SLC6A4
SCHEMBL69873 0.79 TSHR (0.80) BCL2L1BADRXRARXRBTP53
SCHEMBL14018385 0.79 TSHR (0.80) BCL2L1BADRXRARXRBTP53
SCHEMBL2637326 0.79 TSHR (0.80) BCL2L1BADRXRARXRBTP53
Terephthalic Acid SCHEMBL9577834 0.79 TSHR (0.80) BCL2L1BADRXRARXRBTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11512084-B2 Degradation agent using autophagic mechanism of damaged mitochondria TOHOKU UNIVERSITY (JP) 2022-11-29 US disclosed
US-20200223848-A1 DEGRADATION AGENT USING AUTOPHAGIC MECHANISM OF DAMAGED MITOCHONDRIA TOHOKU UNIVERSITY (JP) 2020-07-16 US disclosed
EP-3679935-A1 DEGRADATION AGENT USING AUTOPHAGIC MECHANISM OF DAMAGED MITOCHONDRIA Tohoku University (JP) 2020-07-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200223848-A1 DEGRADATION AGENT USING AUTOPHAGIC MECHANISM OF DAMAGED MITOCHONDRIA HSPA9, ATG7, TFAM SLC22A2 1997/4885SLC22A1 1696/4885SLC22A3 2243/4885
US-11512084-B2 Degradation agent using autophagic mechanism of damaged mitochondria HSPA9, ATG7, TFAM SLC22A2 1997/4885SLC22A1 1696/4885SLC22A3 2243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.